申请人:Brooks Carl
公开号:US20140121206A1
公开(公告)日:2014-05-01
The present invention relates to spirocarbamate compounds of Formula (I) in which R1, (R2)Y, R3, R4, X and A have the meanings given in the specification. The invention further provides pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and relates to their use of these compounds as TRPV4 antagonists in treating or preventing conditions associated with TRPV4 imbalance.
本发明涉及式(I)的螺环氨基甲酸酯化合物,其中R1,(R2)Y,R3,R4,X和A具有规范中给出的含义。本发明还提供了含有这些化合物或其药学上可接受的盐的药物组合物,并涉及将这些化合物用作TRPV4拮抗剂来治疗或预防与TRPV4不平衡相关的疾病。